The current price of ECG is $72.44 — it has decreased by 9.12% since the previous close. Data as of Nov 5, 2026.
ECG is down 28.95% over the past week, down 42.59% over the past month and down 22.34% over the past year. The price is below its 200-day moving average of $125.97.
Analysts' average 12-month price target for ECG is $175.20, which implies 141.86% upside from the current price. Individual estimates range from $152.00 to $200.00.
Of the 7 analysts covering Everus Construction Group, Inc., 5 rate it a buy and 2 rate it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Everus Construction Group, Inc. has a market capitalization of $3.7B. The company belongs to the Industrials sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Everus Construction Group, Inc. posted earnings of $1.79 per share against an estimate of $1.31, beating expectations by 36.64%. Upcoming reports are listed in the earnings calendar.
Everus Construction Group, Inc. reported revenue of $1.38B in its most recent quarter, which has increased by 40.27% compared with the same quarter a year earlier. Analysts had expected $1.19B.
Everus Construction Group, Inc. has not paid any dividends over the past year.
Companies most comparable to Everus Construction Group, Inc. include Quanta Services, Inc., MasTec, Inc., IES Holdings, Inc., Dycom Industries, Inc. and MYR Group Inc.
In the latest trading session ECG moved between $70.44 and $76.91, a range of 8.93% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Everus Construction Group, Inc. shows a strong sell rating today and a strong sell rating on the weekly timeframe. Technical ratings are indicators, not investment advice.
Over the past 52 weeks ECG has traded between $70.44 and $171.58. The current price is 57.78% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.